Mr. Whitehead is a Certified Management Accountant who has held senior financial management positions in several biotechnology and pharmaceutical companies. Most recently he served as Chief Financial Officer of Arius Research Inc., a biotechnology company, providing financial guidance and leadership during the acquisition of Arius by Roche in 2008. Prior to Arius, Mr. Whitehead was Chief Financial Officer at Labopharm Inc., where he completed a series of public equity financings and an initial public offering on the NASDAQ stock exchange. He currently is a member of the Board of Directors of PlantForm Corporation, a life sciences company that develops biosimilar antibody drugs for treatment of cancer and other life-threatening illnesses. Mr. Whitehead received his BA from the University of Western Ontario, and a BComm and MBA from the University of Windsor. Mr. Whitehead is also a Chartered Professional Accountant (CPA) and a Certified Management Accountant (CMA).